Goldman Sachs’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-7,600
Closed -$541K – 6754
2026
Q1
$541K Sell
7,600
-132,400
-95% -$10.4M ﹤0.01% 5554
2025
Q4
$11.5M Hold
140,000
– – ﹤0.01% 2962
2025
Q3
$10.5M Hold
140,000
– – ﹤0.01% 2911
2025
Q2
$10.4M Hold
140,000
– – ﹤0.01% 2724
2025
Q1
$11.3M Buy
140,000
+90,000
+180% +$7.73M ﹤0.01% 2579
2024
Q4
$3.91M Hold
50,000
– – ﹤0.01% 3699
2024
Q3
$4.69M Buy
+50,000
New +$4.2M ﹤0.01% 3395
2023
Q2
– Sell
-18,975
Closed -$1.56M – 5864
2023
Q1
$1.56M Buy
+18,975
New +$1.35M ﹤0.01% 4048

Other funds holding GEHC

Goldman Sachs's GEHC Position: Q2 2026 in Review

Goldman Sachs increased its GE HealthCare (GEHC) stake by 36% in Q2 2026, buying an estimated $77.6M and bringing the position to 4,446,565 shares worth $285M. The position accounts for 0.02% of the portfolio, ranked #615.

Goldman Sachs first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Goldman Sachs held 4,446,565 shares of GE HealthCare worth $285M as of Q2 2026.
  • Goldman Sachs bought 1,180,427 GE HealthCare shares in Q2 2026, an estimated $77.6M.
  • GE HealthCare made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #615 holding.
  • Goldman Sachs first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.